N2 Canada
N2 Canada is a not-for-profit alliance, founded in 2008, that connects roughly 200 member organizations and 3,000+ research professionals across 200+ Canadian sites through Health Canada-accepted SOPs, CITI-Canada training, the CCTAM asset map, and the gDSSA data-sharing framework.
- Company typePrivate
- Founded2008
- HeadquartersMarkham, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What N2 Canada does
N2 Canada is a federally-incorporated, not-for-profit alliance founded in 2008 that serves as the national coordination body for clinical research infrastructure across Canada. It connects nearly 200 member organizations — including academic health centres, universities, cooperative groups, CROs, and pharmaceutical/biotech sponsors — and over 3,000 research professionals operating at more than 200 Canadian sites. Its core purpose is to standardize and professionalize the conduct of clinical trials through shared infrastructure rather than to compete in any commercial market.
The organization's product surface is built around four pillars. First, a library of Clinical Research SOPs that are accepted by Health Canada and refreshed on a multi-year cycle, with the 2026 version published in February 2026. Second, the CITI-Canada education program, whose training is recognized by TransCelerate Biopharma, with more than 265,000 cumulative course completions. Third, the Canadian Clinical Trials Asset Map (CCTAM), a directory of Canadian trial capability, and the Patient Engagement toolkit supporting patient-partner involvement. Fourth, the gDSSA generic Data and Site Sharing Agreement framework, launched in February 2024, which extends N2's standardization mandate from procedures into contractual infrastructure.
N2's business model is membership-funded, with tiered annual dues segmented by organization type (Non-Profit vs. Industry) and size (Large vs. Small). Supplementary revenue comes from independent-learner course fees (CAD $310 + GST per course) and event sponsorships. Strategic partnerships with Clinical Trials BC (since 2017) and CATALIS Québec (since 2022) anchor regional coordination, while the 2026 Clinical Research Workforce Strategy signals a broader mandate toward national workforce development.
N2 Canada firmographics
Firmographics- Name
- N2 Canada
- Legal name
- N2 Canada
- Website
- https://n2canada.ca
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- N2 Canada is a not-for-profit alliance, founded in 2008, that connects roughly 200 member organizations and 3,000+ research professionals across 200+ Canadian sites through Health Canada-accepted SOPs, CITI-Canada training, the CCTAM asset map, and the gDSSA data-sharing framework.
- Ownership category
- akta.pro rank
N2 Canada industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Other Scientific and Technical Consulting Services (541690), Professional, Scientific, and Technical Services (54)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Educational Services (8200)
- akta.pro primary industry
- Clinical Research Support (CRC/CTA) (EDAOAJAO)
- akta.pro secondary industries
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)
Keywords
Where N2 Canada is headquartered
LocationHeadquarters
- HQ city
- Markham
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
N2 Canada business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Revenue model
- Membership Fees: Tiered membership fees based on organization type (Non-Profit or Industry) and size (Large or Small). Provides access to SOPs, CITI-Canada training modules, peer networks, and advocacy services.
- Independent Learner Course Fees: Individual learners not affiliated with member organizations can purchase courses at $310 + GST per course with one year of access from purchase date.
- Event Sponsorships and Registrations: Revenue from annual conferences, regional meetings, and webinars including sponsor partnerships and participant registration fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Membership - Non-Profit Organization |
| Subscription | Annual | Membership - Industry/For-Profit Organization |
| One time/ perpetual license | Pay-as-you-go | Independent Learner Course Access |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
N2 Canada product offering
Product offeringCore offering
N2 Canada provides Health Canada-accepted Standard Operating Procedures (SOPs), jointly-developed Research Ethics Board SOPs (with CAREB-ACCER), and TransCelerate-recognized clinical research education programs (delivered via CITI-Canada) to its member organizations. It also operates the Canadian Clinical Trials Asset Map (CCTAM), a national database of investigators and research sites, alongside patient engagement toolkits, quality management tools, the gDSSA data-sharing framework, and Canada's Clinical Research Workforce Strategy. Services are delivered primarily through a password-protected member portal, the CITI-Canada learning platform, annual conferences, regional meetings, and webinars.
Product overview
N2 Canada is a not-for-profit national alliance of Canadian research networks and organizations, operating for over 18 years to strengthen clinical research capacity and capability across Canada. The organization functions as a platform-plus-resources model rather than a single unified product. Its core offerings center on Health Canada-accepted Standard Operating Procedures (SOPs) for clinical research and Research Ethics Boards (REB SOPs jointly with CAREB-ACCER), which form the foundational compliance framework. Education programs delivered through CITI-Canada include TransCelerate-recognized GCP training and additional courses. The Canadian Clinical Trials Asset Map (CCTAM) provides a national database of investigators and research sites. Member organizations access these resources through the N2 Member Portal and SharePoint platform. Supporting modules include patient engagement toolkits (Permission to Contact, It Starts With Me, The Participators, Ask Me Campaign), quality management and inspection readiness tools, cannabis research compliance tools, privacy guidance, and the gDSSA data-sharing framework. The Canadian Clinical Research Workforce Strategy represents a major national initiative. Additional offerings include the DIY Community Engagement Toolkit, Cultural Competency courses and checklists, and published white papers. Resources are available in both English and French.
Differentiator
Problem solved
Functional benefit
Products and services
- Health Canada-Accepted Standard Operating Procedures (SOPs) Nationally recognized Standard Operating Procedures providing a standardized framework to support ethical, high-quality, and compliant clinical research across Canada, accepted by Health Canada. Available in English and French and updated biennially.
- N2 CAREB-ACCER REB SOPs Jointly developed Research Ethics Board SOPs with CAREB-ACCER providing a standardized Canadian framework for REBs reviewing health-sciences research, meeting Canadian and U.S. regulatory and ethics requirements, available open access in English and French.
- CITI-Canada Education Programs Nationally recognized training courses delivered through the CITI-Canada platform, including TransCelerate-recognized GCP Basic and Refresher courses, RCR, CRC, TDG, Division 5, and more. Available in English and French with certificates of completion.
- Canadian Clinical Trials Asset Map (CCTAM) Pan-Canadian national inventory database of investigators, clinical research sites, hospitals, institutions, research ethics boards (REBs), and other resources supporting clinical research across Canada, with over 1,000 assets.
- Governing Data and Biological Sample Transfers Agreement (gDSSA) National, pre-negotiated framework making data and sample sharing faster, simpler, and more consistent across Canadian institutions, developed by ACT Consortium Contracts Working Group to reduce administrative burden for studies involving secondary use of data or samples.
- N2 Member Portal Password-protected member-only site providing access to N2 SharePoint with exclusive tools and resources including SOPs, Quality Tools, training documents, the Canadian Clinical Trials Asset Map (CCTAM), and the membership payment portal.
- Canada's Clinical Research Workforce Strategy National initiative focused on strengthening capacity, sustainability, and career pathways across the clinical research workforce, including Leadership Committee, Taskforces on Role Classifications, Talent/Compensation/Equity, and CRP Pathways, plus Francophone Engagement and Industry Engagement Tables.
- Permission to Contact (PTC) Toolkit Patient-centred enrollment strategy toolkit that helps research teams connect with people interested in future studies through a routine question approach, reducing barriers to participation. Includes budgeting, data-planning support, and implementation guidance.
- Biospecimen-Related SOPs Standardized approach to collecting, processing, storing, and distributing biospecimens developed through OICR's HICT program and OTRN. Organized into three series (000 - General SOPs, 100 - Biorepository SOPs, 200 - Clinical Trial SOPs), accessible at 3CTN.ca.
- Cultural Competency Course and Self-Assessment Checklist Self-assessment checklist helping clinical research professionals reflect on cultural competency when working with diverse populations, grounded in EDIA principles. Promotes professional growth by examining awareness, attitudes, knowledge, and practices.
Quantifiable outcome
- 265,000+ courses completed across Canada
- +2 more outcomes
Companies that use N2 Canada
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
N2 Canada technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
Feature4 records
N2 Canada partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- CITI Canada (Collaborative Institutional Training Initiative)coreN2 partners with CITI to deliver the national online learning platform featuring TransCelerate-recognized courses tailored to Canadian guidelines. Available in English and French, the CITI-Canada curriculum includes eight interactive courses covering GCP, RCR, Division 5, TDG, and more.
- CAREB-ACCERcoreN2 and CAREB-ACCER jointly developed standardized Canadian REB SOPs providing a national framework for Research Ethics Boards reviewing health-sciences research. These SOPs meet Canadian and U.S. regulatory requirements and are available open access in English and French.
- ACT Consortium (Accelerating Clinical Trials)coreACT Consortium leads national clinical trial transformation efforts. N2 collaborates on shared initiatives including the gDSSA framework developed by the ACT Consortium Contracts Working Group for governing data and biological sample transfers.
- 3CTN (Canadian Cancer Clinical Trials Network)core3CTN supports clinical trial capacity through site financing and the biospecimen-related SOPs developed in coordination with OICR's High Impact Clinical Trials program. N2 provides access to clinical trial SOPs through 3CTN.ca.
- Obero (Ontario Breast Registry)minorDeveloped the Permission to Contact (PTC) Toolkit in partnership with OBER, Island Health, and CTRNet to support consistent adoption of patient enrollment practices across Canada.
- CIHR (Canadian Institutes of Health Research)coreN2 supports Canada's Clinical Research Workforce Strategy, a national initiative addressing workforce capacity and career pathways. CIHR provides leadership through the External Advisory Group supporting this transformative initiative.
- Clinical Trials British ColumbiacoreSince 2017, Clinical Trials British Columbia has partnered with N2 to offer provincial membership, funding 6 memberships and supporting 852 new learners between 2022-2024. Provides designated lead administrators managing access for affiliated research sites.
- CATALIS QuébeccoreSince 2022, CATALIS Québec serves as the provincial representative connecting 25 healthcare institutions across Quebec with N2's national tools and resources, ensuring French and English accessibility.
- OICR (Ontario Institute for Cancer Research) - HICT ProgramcoreDeveloped biospecimen-related SOPs through coordinated effort by OICR's High Impact Clinical Trials program and Ontario Translational Research Network to address gaps in biospecimen standards.
- CTRNet (Canadian Tissue Repository Network)minorNational biobank consortium providing standards for tissue and biospecimen collection, storage, and distribution. Collaborated on Permission to Contact toolkit development.
- TransCelerate BioPharmacoreN2's GCP Basic and Refresher courses are recognized by TransCelerate for mutual GCP training acceptance, enabling streamlined compliance across international clinical trials.
- RareKids-CANminorCIHR-funded national pediatric rare disease clinical trials network. N2 supports workforce development and resource sharing for pediatric and maternal clinical trials.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
N2 Canada competitors and assessment
Company assessmentRegional players
- Clinical Trials Ontario: Clinical Trials Ontario is a provincial non-profit that streamlines clinical trial processes, provides site tools, and supports workforce development in Ontario — a sub-national peer whose scope and mission (REB streamlining, site support, training) partially overlap with N2's offerings.
- NIHR Clinical Research Network: The UK's NIHR Clinical Research Network coordinates clinical research delivery across the NHS and provides training, infrastructure, and workforce support — a regional equivalent of N2's pan-Canadian coordination, SOP standardization, and CCTAM-style site inventory role.
- ARCS Australia: ARCS Australia is the national association for the Australian regulatory, clinical, and biotech workforce, offering training, events, and workforce development — a regional analog to N2's Canadian clinical research professional development mission.
- European Clinical Research Infrastructure Network (ECRIN): ECRIN is a European non-profit infrastructure supporting multinational clinical research with SOPs, training, and site management tools — comparable to N2's mission of standardizing clinical research practices across a multi-country/multi-institution network.
Direct peers
- Society for Clinical Research Sites (SCRS): SCRS is a global trade organization representing clinical research sites and site networks, offering member resources, education, and advocacy. Comparable to N2's site-network membership model connecting 200+ research sites across Canada.
- Public Responsibility in Medicine and Research (PRIM&R): PRIM&R is a non-profit that provides ethics and oversight education for the research enterprise, including IRB/REB training and resources — comparable to N2's joint CAREB-ACCER REB SOPs and regulatory ethics resources.
- Society of Clinical Research Associates (SOCRA): SOCRA is a non-profit membership organization that certifies Clinical Research Professionals (CCRP) and delivers GCP and clinical research training — directly parallel to N2's CITI-Canada TransCelerate-recognized training program.
- Association of Clinical Research Professionals (ACRP): ACRP is a global non-profit membership organization providing training, certification (CCRC, CCRA, CPI, ACRP-CP), and professional development for clinical research professionals — directly comparable to N2's CITI-Canada training and CRC course offerings.
Emerging players
- MAGI (Model Agreements & Guidelines International): MAGI is a membership organization focused on standardizing clinical trial contracts, budgets, and operations practices — overlapping with N2's gDSSA pre-negotiated framework and SOP standardization activities, with a more specialized scope.
Broad incumbents
- Drug Information Association (DIA): DIA is a large global life sciences association offering conferences, training, and publications across the full drug development lifecycle. Comparable as an industry-wide membership and education body but far broader in scope than N2's Canada-focused clinical research niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
N2 Canada social profiles
Digital presenceN2 Canada financial estimates
Financial estimateRevenue estimate
Valuation estimate
N2 Canada leadership team
Management profileNumber of profiles
Profiles3 records
N2 Canada funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
N2 Canada M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about N2 Canada
What does N2 Canada do?
N2 Canada provides Health Canada-accepted Standard Operating Procedures (SOPs), jointly-developed Research Ethics Board SOPs (with CAREB-ACCER), and TransCelerate-recognized clinical research education programs (delivered via CITI-Canada) to its member organizations. It also operates the Canadian Clinical Trials Asset Map (CCTAM), a national database of investigators and research sites, alongside patient engagement toolkits, quality management tools, the gDSSA data-sharing framework, and Canada's Clinical Research Workforce Strategy. Services are delivered primarily through a password-protected member portal, the CITI-Canada learning platform, annual conferences, regional meetings, and webinars.
Is N2 Canada a public or private company?
N2 Canada is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was N2 Canada founded?
N2 Canada was founded in 2008. It employs 1 to 10 people.
Where is N2 Canada based?
N2 Canada is headquartered in Markham, Canada, in the North America region.
How does N2 Canada make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are independent Learner Course Fees and event Sponsorships and Registrations.
Who are N2 Canada's main competitors?
Regional players on record are Clinical Trials Ontario, NIHR Clinical Research Network, ARCS Australia and European Clinical Research Infrastructure Network (ECRIN). Direct peers are Society for Clinical Research Sites (SCRS), Public Responsibility in Medicine and Research (PRIM&R), Society of Clinical Research Associates (SOCRA) and Association of Clinical Research Professionals (ACRP). MAGI (Model Agreements & Guidelines International) is listed as an emerging player. Drug Information Association (DIA) is listed as a broad incumbent.
Does N2 Canada have an API?
No public API is recorded for N2 Canada.
What industry is N2 Canada in?
N2 Canada's product category is Clinical Research Services. Its primary akta.pro industry code is EDAOAJAO, Clinical Research Support (CRC/CTA), with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 541690 and its SIC code is 8090.